- Home
- EVAX vs REBN Comparison
EVAX vs REBN Comparison
Compare EVAX & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- REBN
- Stock Information
- Founded
- EVAX 2008
- REBN 2015
- Country
- EVAX Denmark
- REBN United States
- Employees
- EVAX N/A
- REBN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- REBN Restaurants
- Sector
- EVAX Health Care
- REBN Consumer Discretionary
- Exchange
- EVAX Nasdaq
- REBN Nasdaq
- Market Cap
- EVAX 16.3M
- REBN 18.5M
- IPO Year
- EVAX 2021
- REBN 2022
- Fundamental
- Price
- EVAX $2.55
- REBN $5.59
- Analyst Decision
- EVAX Strong Buy
- REBN
- Analyst Count
- EVAX 3
- REBN 0
- Target Price
- EVAX $33.33
- REBN N/A
- AVG Volume (30 Days)
- EVAX 7.0M
- REBN 7.6M
- Earning Date
- EVAX 03-26-2025
- REBN 03-27-2025
- Dividend Yield
- EVAX N/A
- REBN N/A
- EPS Growth
- EVAX N/A
- REBN N/A
- EPS
- EVAX N/A
- REBN N/A
- Revenue
- EVAX $3,295,000.00
- REBN $5,502,528.00
- Revenue This Year
- EVAX $9,039.73
- REBN $185.18
- Revenue Next Year
- EVAX $1.47
- REBN $64.55
- P/E Ratio
- EVAX N/A
- REBN N/A
- Revenue Growth
- EVAX N/A
- REBN 9.70
- 52 Week Low
- EVAX $2.22
- REBN $0.92
- 52 Week High
- EVAX $22.05
- REBN $8.80
- Technical
- Relative Strength Index (RSI)
- EVAX 40.73
- REBN 70.22
- Support Level
- EVAX $2.42
- REBN $3.64
- Resistance Level
- EVAX $2.80
- REBN $6.41
- Average True Range (ATR)
- EVAX 0.32
- REBN 1.18
- MACD
- EVAX 0.05
- REBN 0.09
- Stochastic Oscillator
- EVAX 18.03
- REBN 77.03
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.